SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-96-000013
Filing Date
1996-11-05
Accepted
1996-11-05 00:00:00
Documents
10
Period of Report
1996-09-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 10-Q 61340
2 AMENDED AND RESTATED 1991 EQUITY INCENTIVE PLAN EX-10.1 39601
3 AMENDED AND RESTATED 1984 STOCK OPTION PLAN EX-10.2 31719
4 AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN EX-10.7 24286
5 AMENDED AND RESTATED 1987 DIRECTORS' STOCK OPTION PLAN EX-10.13 20149
6 AMENDED AND RESTATED 1988 STOCK OPTION PLAN EX-10.14 36138
7 FIRST AMENDMENT TO THE AMGEN RETIREMENT AND SAVINGS EX-10.42 6763
8 COMPUTATION OF PER SHARE EARNINGS EX-11 3074
9 FINANCIAL DATA SCHEDULE EX-27 2024
10 RISK FACTORS EX-99 10530
  Complete submission text file 0000318154-96-000013.txt   238284
Mailing Address 1840 DEHAVILLAND DR. MAIL STOP 10-1-B-512 THOUSAND OAKS CA 91320-1789
Business Address 1840 DEHAVILLAND DR THOUSAND OAKS CA 91320-1789 0854471000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 96654481
SIC: 2836 Biological Products, (No Diagnostic Substances)